By Doug Young & Rene Vanguestaine

A two-year-old corruption clampdown in China’s sprawling tobacco monopoly and regulator has netted nearly 20 senior officials and executives.

Why doesn’t any other company or sector contribute revenue as abundantly and consistently to central government coffers as China Tobacco? Will China ever get serious about stamping out smoking more aggressively?

And real time engagement tech maker Agora announces plans to split in two, one half for its China business and the other for the rest of the world. Is this the wave of the future for China tech?

About China Inc

China Inc by Bamboo Works discusses the latest developments on Chinese companies listed in Hong Kong and the United States to drive informed decision-making for investors and others interested in this dynamic group of companies.

Subscribe to China Inc on your favorite app:

Apple Podcasts Spotify

Recent Articles

Butong made an IPO

BRIEF: Haixi Pharma delays IPO trading debut

Fujian Haixi Pharmaceuticals Co. Ltd. (2637.HK) said on Thursday night that the trading debut for its Hong Kong IPO, originally scheduled for Friday, will be postponed. It blamed the delay…